I. Melezínek
19 works · 2,725 citations · h-index 10
Top works
- Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
- Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer
- BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP
- Clinical outcomes in non‐small‐cell lung cancer patients with EGFR mutations: pooled analysis
- Treatment outcome according to tumor RAS mutation status in CRYSTAL study patients with metastatic colorectal cancer (mCRC) randomized to FOLFIRI with/without cetuximab.
- Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function
- The role of prostate specific antigen measurement in the detection and management of prostate cancer.
- Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
- The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study
- Interference of melanin in protein determination
- Tumour tissue is a source of ?? -glutamyl transpeptidase sialoform in the sera of melanomabearing mice
- Outcome According to Tumor Ras Mutation Status in Crystal Study Patients with Metastatic Colorectal Cancer Randomized to Folfiri with or Without Cetuximab as First-Line Treatment
- [Gamma-glutamyltranspeptidase as a tumor marker].
- Evaluation of the role of body-surface-area dose adjustment of ZD6126, a novel vascular-targeting agent
- 9154 Clinical outcomes in patients with EGFR mutations: pooled analysis of NSCLC patients treated with either an EGFR TKI or chemotherapy
- Analysis of results of bicalutamide monotherapy versus castration in patients with non-metastatic locally advanced prostate cancer during 6.3-year follow-up
- Сравнительный анализ результатов монотерапии бикалютамидом и кастрации у больных неметастатическим местно-распространенным раком предстательной железы при сроке наблюдения 6,3 года